MedPath

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Completed
Conditions
Myocardial Infarction
Registration Number
NCT00196287
Lead Sponsor
Deutsches Herzzentrum Muenchen
Brief Summary

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
750
Inclusion Criteria

acute myocardial infarction; female gender

Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

1. Medizinische Klinik, Klinikum rechts der Isar

🇩🇪

Munich, Germany

Deutsches Herzzentrum Muenchen

🇩🇪

Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath